Navigation Links
Walgreens' Mike Ellis Named First President of National Association of Specialty Pharmacy (NASP)
Date:10/23/2013

ALEXANDRIA, Va., Oct. 23, 2013 /PRNewswire-iReach/ -- Mike Ellis, corporate vice president, specialty pharmacy and infusion services for Walgreens, has been named the first president of the National Association of Specialty Pharmacy (NASP)

"This is an exciting time for specialty pharmacy and I'm excited to work with my colleagues on this distinguished Board of Directors to advance NASP's mission and create a stronger, more unified voice for all stakeholders," said Ellis.  "At Walgreens, we share NASP's dedication to serve the needs of patients living with complex, chronic health conditions and support the pharmacists they work with on a daily basis." 

Before joining Walgreens in 2011, Ellis served as senior vice president of specialty trade relations and contracting and pharmaceutical services for CVS Caremark. He has more than 32 years of specialty pharmacy and infusion experience and has held senior-level industry positions at AdvancePCS, Olsten Health Services and Quantum Health Resources. Ellis is a licensed pharmacist and earned his Bachelor of Science in pharmacy from the University of Arkansas College of Pharmacy.

Walgreens, one of the largest national providers of injectable, infused and biopharmaceutical medications, joined NASP as a founding member last year. With an integrated, multi-channel model inclusive of local specialty and infusion services, Walgreens focuses on creating an optimal patient experience that supports improved health outcomes. Walgreens also offers pipeline insights, custom reporting and innovative clinical and utilization management programs to help payers manage costs.

"We are honored to work with Mike as our first president, guiding NASP forward as it continues to lead the specialty pharmacy industry," Gary M. Cohen, BSPharm, RPh, CSP, NASP CEO, said. "Walgreens is a strong supporter of our membership
'/>"/>

SOURCE National Association of Specialty Pharmacy
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. AnaptysBio Named a 2013 "Fierce 15" Winner
2. Beaumont named to 2013 InformationWeek 500 list of top technology innovators
3. Dr. Paul J. Reilly, MD, FAAFP, is Named Strax Rejuvenations Doctor of the Month for August
4. Helper cells aptly named in battle with invading pathogens
5. Tufts Engineer Qiaobing Xu named 2013 Pew Scholar
6. TGens Huentelman and Weiss named to 2013 Class of 40 Under 40
7. NYU Langone Medical Center researcher named Howard Hughes Investigator
8. St. Jude scientist named Howard Hughes Medical Institute investigator
9. Monell alum Dr. Larry Clark named Centers 2013 Kerry-Manheimer awardee
10. Student named universitys first Lawrence scholar, researching at national laboratory
11. Developmental biologist Arthur Lander named Donald Bren Professor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2014)... patients referred for evaluation of suspected genetic conditions, ... 25 percent, including detection of a number of ... disease, according to a study appearing in ... coincide with the American Society of Human Genetics ... or coding regions of thousands of genes simultaneously ...
(Date:10/17/2014)... news release is available in German . ... millions of sperms every day in order to reproduce? And ... are the topic of the latest issue of the research ... 2014). The evolutionary biologist Steven Ramm from Bielefeld University Bielefeld ... it is not unusual for a female to copulate with ...
(Date:10/16/2014)... body. Battles are won, lost or sometimes end ... as tumor dormancy—can last up to 25 years ... poorly understood. , A new computational model ... Professor of Chemistry at Princeton University, may help ... switch to a malignant state. Published today in ...
Breaking Biology News(10 mins):Whole-exome sequencing shows potential as diagnostic tool 2Sperm wars 2Modeling tumor dormancy 2
... the National Institutes of Health (NIH) have determined the ... Borrelia burgdorferi , the bacteria that cause Lyme disease. ... how genetic variations among strains may result in different ... most common tickborne disease in North America. The wealth ...
... 2010 - Alcohol is one of the most commonly ... likely to develop alcoholism as women. Until now, the ... remained unclear. A new study published in Biological ... factor. Researchers from Columbia and Yale studied male and ...
... understand the effects of climate change on the microbial ... and the tundra in Alaska, a University of Oklahoma ... of Energy grant. According to Jizhong Zhou, OU ... Institute for Environmental Genomics, the results of these studies ...
Cached Biology News:Why are men more susceptible to alcoholism? 2
(Date:10/22/2014)... 2014 Involution Studios , a ... a new infographic, Understanding Ebola . The ... designed, easy to follow informative tool for anyone wanting ... symptoms and prevention. , "As the news has spread ... Ebola outbreak represents not only a healthcare crisis with ...
(Date:10/22/2014)... October 22, 2014 Physicians Choice ... cardiovascular pharmacogenetics menu, which enables healthcare providers to ... With PCLS’s evidence-based results, healthcare providers are better ... their therapy, while minimizing risks for adverse drug ... according to the FDA [1] more than 2.2 ...
(Date:10/22/2014)... 22, 2014 Nuvilex, Inc. (OTCQB: NVLX) – ... people worldwide are living with diabetes, with  that number ... The global market for diabetes treatments is approximately $500 ... worldwide died from pancreatic cancer.  Pancreatic cancer is the ... in the United States , and ...
(Date:10/20/2014)... , Oct. 20, 2014 Mapp ... experimental ZMapp™ antibody therapeutic to fight the Ebola ... difficult and time-consuming the production of pharmaceuticals can ... research publisher said that while some may be ... this compound, those with industry knowledge are well ...
Breaking Biology Technology:Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3
... Inc. (OTC: MSEL) operating under its principal brand ... of visual communications and brand imaging solutions, was awarded " ... 9th Annual American Business Awards Ceremony, in recognition of its ... solid results, despite prevailing economic turbulence. The American ...
... 2011 Amylin Pharmaceuticals, Inc. (Nasdaq: ... present data for its two first-in-class diabetes drugs, ... and its investigational diabetes drug candidates BYDUREON™ (exenatide ... at the 71st Scientific Sessions of the American ...
... 2011 Scientists Drs. Samuel and Elenore Bogoch of BioRadar ... in Replikin Counts of the EHEC lethal strains of E. ... of E. Coli have been studied in laboratories in Germany ... in the public databases. Replikins are subsequences of the genome ...
Cached Biology Technology:Merisel, Inc. Wins Business Turnaround of the Year at the 2011 American Business Awards 2Merisel, Inc. Wins Business Turnaround of the Year at the 2011 American Business Awards 3Merisel, Inc. Wins Business Turnaround of the Year at the 2011 American Business Awards 4Merisel, Inc. Wins Business Turnaround of the Year at the 2011 American Business Awards 5Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 2Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 3Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 4Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 5Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 6Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 7Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 8Rising Replikin Counts in E. Coli in Germany Since 2005 Preceded Current E. Coli Outbreak 2Rising Replikin Counts in E. Coli in Germany Since 2005 Preceded Current E. Coli Outbreak 3
...
Mouse anti-JNK (PT183/185) Class: Antibody Product Group: Signalling molecules and phospho-specific Antibody...
Acetyl CoA Carboxylase Antibody...
mu Opioid Receptor splice variant Immunogen: Synthetic peptide corresponding to residues K S C M D R G M R N L L P D D G P R Q E of Mu Opioid Receptor. Storage: -20 C, Avoid Freeze/Thaw Cycle...
Biology Products: